Linagliptin demonstrates cardiovascular and renal safety in Asian adults with type 2 diabetes EP News Bureau Jun 30, 2020 In a sub-analysis of the CAROLINA cardiovascular outcome trial, linagliptin demonstrated no increased cardiovascular risk versus…
